Hanmi Science: 투자판단관련주요경영사항(자회사의 주요경영사항)
AI reading
★★★★★ Bullish · Material event
자회사 한미약품의 HM17321 기술이전 계약 체결
Key figures: 계약금액 약 3조 1,892억원(Upfront 2,629억원, 마일스톤 2조 9,263억원)
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
Other filings by Hanmi Science
For information only. Not investment advice.